PTPN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.376600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.684300E-02
Normal-vs-Stage2
2.004200E-01
Normal-vs-Stage3
3.845800E-02
Normal-vs-Stage4
2.236800E-01
Stage1-vs-Stage2
1.854200E-01
Stage1-vs-Stage3
5.314000E-01
Stage1-vs-Stage4
5.239800E-01
Stage2-vs-Stage3
8.827800E-02
Stage2-vs-Stage4
7.061600E-01
Stage3-vs-Stage4
3.297800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.589440E-01
Normal-vs-AfricanAmerican
3.417600E-01
Normal-vs-Asian
1.321990E-02
Caucasian-vs-AfricanAmerican
5.658800E-01
Caucasian-vs-Asian
1.816420E-01
AfricanAmerican-vs-Asian
1.634160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.627970E-01
Normal-vs-Female
1.177350E-01
Male-vs-Female
9.087000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.928000E-01
Normal-vs-Age(41-60Yrs)
4.815800E-01
Normal-vs-Age(61-80Yrs)
2.831800E-02
Normal-vs-Age(81-100Yrs)
4.161200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.995800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.384000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.249400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.3655999999983E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.420800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.520000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.533700E-02
Normal-vs-Daily Drinker
2.471600E-01
Normal-vs-Weekly Drinker
4.363700E-02
Normal-vs-Occasional Drinker
2.811000E-01
Normal-vs-Social Drinker
5.174600E-01
Non Drinker-vs-Daily Drinker
9.065800E-01
Non Drinker-vs-Weekly Drinker
6.223200E-01
Non Drinker-vs-Occasional Drinker
4.233000E-01
Non Drinker-vs-Social Drinker
1.978960E-01
Daily Drinker-vs-Weekly Drinker
6.799000E-01
Daily Drinker-vs-Occasional Drinker
6.391000E-01
Daily Drinker-vs-Social Drinker
3.230400E-01
Weekly Drinker-vs-Occasional Drinker
3.319000E-01
Weekly Drinker-vs-Social Drinker
1.398560E-01
Occasional Drinker-vs-Social Drinker
5.514800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.426800E-01
Normal-vs-Grade 2
9.288400E-01
Normal-vs-Grade 3
4.515200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.040500E-02
Grade 1-vs-Grade 3
1.001190E-03
Grade 1-vs-Grade 4
9.426800E-01
Grade 2-vs-Grade 3
1.912450E-02
Grade 2-vs-Grade 4
9.288400E-01
Grade 3-vs-Grade 4
4.515200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.189800E-02
Normal-vs-NonDiabetic
1.665370E-01
Diabetic-vs-NonDiabetic
2.003800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.133800E-01
Normal-vs-NoPancreatitis
1.167970E-01
Pancreatitis-vs-NoPancreatitis
3.153200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.175500E-02
Normal-vs-N1
1.799570E-01
N0-vs-N1
2.111200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.083800E-01
Normal-vs-TP53-NonMutant
9.965700E-02
TP53-Mutant-vs-TP53-NonMutant
2.598100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
